Open Access

[Retracted] Paclitaxel increases the sensitivity of lung cancer cells to lobaplatin via PI3K/Akt pathway

  • Authors:
    • Dongjie Ma
    • Shanqing Li
    • Yushang Cui
    • Li Li
    • Hongsheng Liu
    • Yeye Chen
    • Xiaoyun Zhou
  • View Affiliations

  • Published online on: January 21, 2021     https://doi.org/10.3892/ol.2021.12480
  • Article Number: 219
  • Copyright : © Ma et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Oncol Lett 15: [Related article:] 6211-6216, 2018; DOI: 10.3892/ol.2018.8086

Following the publication of the above paper, it was drawn to the authors’ attention by an interested reader that the scratch-wound assay images featured in Fig. 5A were, broadly speaking, rather similar, even though they were intending to show the results from three separate experiments, and there also appeared to be repeating, identical cellular patterns within the images themselves in this Figure part. The authors replied to the Editorial Office to explain that errors were made during the process of uploading the images, and also to request a retraction of the paper.

The Editor of Oncology Letters has concurred that this article should be retracted, and all the authors agreed with the retraction. The Editor apologizes to the readership for any inconvenience caused.

Related Articles

Journal Cover

March-2021
Volume 21 Issue 3

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Ma D, Li S, Cui Y, Li L, Liu H, Chen Y and Zhou X: [Retracted] Paclitaxel increases the sensitivity of lung cancer cells to lobaplatin via PI3K/Akt pathway. Oncol Lett 21: 219, 2021.
APA
Ma, D., Li, S., Cui, Y., Li, L., Liu, H., Chen, Y., & Zhou, X. (2021). [Retracted] Paclitaxel increases the sensitivity of lung cancer cells to lobaplatin via PI3K/Akt pathway. Oncology Letters, 21, 219. https://doi.org/10.3892/ol.2021.12480
MLA
Ma, D., Li, S., Cui, Y., Li, L., Liu, H., Chen, Y., Zhou, X."[Retracted] Paclitaxel increases the sensitivity of lung cancer cells to lobaplatin via PI3K/Akt pathway". Oncology Letters 21.3 (2021): 219.
Chicago
Ma, D., Li, S., Cui, Y., Li, L., Liu, H., Chen, Y., Zhou, X."[Retracted] Paclitaxel increases the sensitivity of lung cancer cells to lobaplatin via PI3K/Akt pathway". Oncology Letters 21, no. 3 (2021): 219. https://doi.org/10.3892/ol.2021.12480